Literature DB >> 21107630

Recanalization therapy for acute ischemic stroke, part 2: mechanical intra-arterial technologies.

Saeed Ansari1, Maryam Rahman, Douglas J McConnell, Michael F Waters, Brian L Hoh, J Mocco.   

Abstract

Stroke therapy has been revolutionized in the past two decades with the widespread implementation of chemical thrombolysis for acute stroke. However, chemical thrombolysis continues to be limited in its efficacy secondary to relatively short time windows and a high associated risk of hemorrhage. In an attempt to minimize hemorrhagic complications and extend the available therapeutic window, mechanical devices designed specifically for thrombus removal, clot obliteration, and arterial revascularization have experienced a recent surge in development and utilization. As such, chemical thrombolytics now represent only one of many options in acute stroke therapy. These new mechanical devices have extended the potential treatment window and now provide alternatives to patients who do not respond to conventional intravenous thrombolysis. This review will discuss the development of these devices, supporting literature, and the individual strengths that each engenders towards a life-saving therapy for stroke.

Entities:  

Mesh:

Year:  2010        PMID: 21107630     DOI: 10.1007/s10143-010-0294-1

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  65 in total

Review 1.  The use of stents in the management of neurovascular disease: a review of historical and present status.

Authors:  M B Horowitz; P D Purdy
Journal:  Neurosurgery       Date:  2000-06       Impact factor: 4.654

2.  Intraarterial suction thrombectomy in acute stroke.

Authors:  Helmi L Lutsep; Wayne M Clark; Gary M Nesbit; Todd A Kuether; Stan L Barnwell
Journal:  AJNR Am J Neuroradiol       Date:  2002-05       Impact factor: 3.825

3.  Multimodal therapy for the treatment of severe ischemic stroke combining GPIIb/IIIa antagonists and angioplasty after failure of thrombolysis.

Authors:  Alex Abou-Chebl; Christopher T Bajzer; Derk W Krieger; Anthony J Furlan; Jay S Yadav
Journal:  Stroke       Date:  2005-09-22       Impact factor: 7.914

4.  Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review.

Authors:  W D Weaver; R J Simes; A Betriu; C L Grines; F Zijlstra; E Garcia; L Grinfeld; R J Gibbons; E E Ribeiro; M A DeWood; F Ribichini
Journal:  JAMA       Date:  1997-12-17       Impact factor: 56.272

5.  The Merci Retrieval System for acute stroke: the Southeast Regional Stroke Center experience.

Authors:  T G Devlin; B W Baxter; T A Feintuch; N A Desbiens
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

6.  Recanalization of an acute middle cerebral artery occlusion using a self-expanding, reconstrainable, intracranial microstent as a temporary endovascular bypass.

Authors:  Michael E Kelly; Anthony J Furlan; David Fiorella
Journal:  Stroke       Date:  2008-04-03       Impact factor: 7.914

7.  Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results.

Authors: 
Journal:  Stroke       Date:  2004-04-22       Impact factor: 7.914

8.  First Food and Drug Administration-approved prospective trial of primary intracranial stenting for acute stroke: SARIS (stent-assisted recanalization in acute ischemic stroke).

Authors:  Elad I Levy; Adnan H Siddiqui; Annemarie Crumlish; Kenneth V Snyder; Erik F Hauck; David J Fiorella; L Nelson Hopkins; J Mocco
Journal:  Stroke       Date:  2009-08-20       Impact factor: 7.914

9.  Comparison of mechanical embolectomy and intraarterial thrombolysis in acute ischemic stroke within the MCA: MERCI and Multi MERCI compared to PROACT II.

Authors:  S Andrew Josephson; Jeffrey L Saver; Wade S Smith
Journal:  Neurocrit Care       Date:  2008-11-22       Impact factor: 3.210

10.  Treatment of basilar artery embolism with a mechanical extraction device: necessity of flow reversal.

Authors:  Thomas E Mayer; Gerhard F Hamann; Hartmut J Brueckmann
Journal:  Stroke       Date:  2002-09       Impact factor: 7.914

View more
  3 in total

Review 1.  Beyond the time window of intravenous thrombolysis: standing by or by stenting?

Authors:  Xinfeng Liu
Journal:  Interv Neurol       Date:  2012-05

Review 2.  Perlecan domain V therapy for stroke: a beacon of hope?

Authors:  Gregory J Bix
Journal:  ACS Chem Neurosci       Date:  2012-12-24       Impact factor: 4.418

Review 3.  Evidence for high translational potential of mesenchymal stromal cell therapy to improve recovery from ischemic stroke.

Authors:  Mark A Eckert; Quynh Vu; Kate Xie; Jingxia Yu; Wenbin Liao; Steven C Cramer; Weian Zhao
Journal:  J Cereb Blood Flow Metab       Date:  2013-06-12       Impact factor: 6.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.